US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 63.690
  • +0.410+0.65%
Close Apr 30 16:00 ET
  • 63.690
  • 0.0000.00%
Post 20:01 ET
12.21BMarket Cap28.82P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
17.97%2.85B
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
Operating revenue
17.97%2.85B
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
Cost of revenue
9.05%580.24M
-1.30%136.14M
47.18%188.46M
-0.12%130.46M
-7.60%125.18M
5.77%532.06M
-5.94%137.93M
10.11%128.04M
6.09%130.62M
15.82%135.47M
Gross profit
20.48%2.27B
20.24%611.17M
22.94%557.28M
25.16%581.57M
13.60%523.65M
18.46%1.89B
30.03%508.28M
16.51%453.29M
13.15%464.66M
14.55%460.94M
Operating expense
5.77%1.8B
-6.48%449.8M
16.81%443.41M
15.54%461.12M
11.71%445.19M
10.79%1.7B
19.24%480.98M
-2.80%379.6M
7.68%399.09M
7.40%398.54M
Selling and administrative expenses
13.07%1.01B
2.74%266.6M
46.87%253.5M
27.62%263.03M
7.05%225.91M
8.41%892.4M
20.75%259.5M
-20.39%172.6M
4.71%206.1M
8.43%211.02M
-Selling and marketing expense
-2.40%476.7M
-5.71%125.6M
-10.66%108.9M
6.23%122.8M
----
8.46%488.4M
6.90%133.2M
9.52%121.9M
5.67%115.6M
----
-General and administrative expense
31.76%532.3M
11.64%141M
185.21%144.6M
54.95%140.23M
----
8.34%404M
39.87%126.3M
-51.94%50.7M
3.51%90.5M
----
Research and development costs
0.06%747.18M
-15.87%173.51M
-3.35%184.9M
3.62%183.79M
19.29%204.99M
14.96%746.77M
19.39%206.25M
21.22%191.31M
12.12%177.36M
6.85%171.85M
Depreciation amortization depletion
-30.39%43.3M
-36.33%9.69M
-68.06%5.01M
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.03%15.23M
-1.38%15.68M
0.19%15.62M
0.37%15.67M
-Depreciation and amortization
-30.39%43.3M
-36.33%9.69M
-68.06%5.01M
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.03%15.23M
-1.38%15.68M
0.19%15.62M
0.37%15.67M
Operating profit
155.23%474.2M
491.06%161.37M
54.52%113.87M
83.71%120.45M
25.73%78.46M
223.62%185.79M
319.17%27.3M
5,102.92%73.69M
63.70%65.57M
99.20%62.4M
Net non-operating interest income expense
41.51%62.15M
1.18%15.04M
26.12%15.09M
83.03%16.21M
91.97%15.82M
1,110.95%43.92M
123.60%14.86M
3,637.81%11.96M
754.14%8.86M
514.90%8.24M
Non-operating interest income
28.36%74.88M
-2.02%17.68M
14.70%18.05M
56.87%19.79M
62.15%19.37M
223.49%58.34M
107.16%18.04M
214.86%15.74M
403.47%12.61M
556.21%11.94M
Non-operating interest expense
-10.74%12.34M
-13.03%2.25M
-21.46%2.97M
-4.82%3.57M
-4.21%3.55M
0.07%13.82M
75.99%2.59M
-19.23%3.78M
-2.69%3.76M
-2.71%3.7M
Total other finance cost
-34.18%391K
----
----
----
----
0.17%594K
----
----
----
----
Other net income (expense)
113.95%5.33M
65.47%-6.87M
768.67%5.46M
-25.30%-4.53M
181.13%11.27M
-142.40%-38.22M
-95.96%-19.9M
-15.56%-817K
6.08%-3.61M
-113.25%-13.89M
Special income (charges)
--10M
--0
--0
--0
--10M
--0
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
--0
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--10M
--0
--0
--0
--10M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
87.78%-4.67M
65.47%-6.87M
768.67%5.46M
-25.30%-4.53M
109.12%1.27M
-183.87%-38.22M
-108.27%-19.9M
-523.32%-817K
-22.60%-3.61M
-1,103.38%-13.89M
Income before tax
187.31%541.76M
777.73%169.64M
222.64%134.44M
86.61%132.14M
85.96%105.55M
26.07%188.56M
210.08%19.33M
2,288.50%41.67M
103.18%70.81M
-57.70%56.76M
Income tax
449.31%114.9M
4,364.89%44.7M
2,096.82%28.36M
69.00%24.96M
185.94%16.89M
160.99%20.92M
93.95%-1.05M
-72.81%1.29M
105.51%14.77M
-55.90%5.91M
Net income
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
Net income continuous Operations
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
Minority interest income
Net income attributable to the parent company
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
Basic earnings per share
152.81%2.25
500.00%0.66
166.67%0.56
86.67%0.56
74.07%0.47
17.11%0.89
8,315.09%0.11
625.00%0.21
100.00%0.3
-59.09%0.27
Diluted earnings per share
154.02%2.21
481.82%0.64
161.90%0.55
89.66%0.55
70.37%0.46
16.00%0.87
8,315.09%0.11
625.00%0.21
93.33%0.29
-57.14%0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 17.97%2.85B15.65%747.31M28.28%745.74M19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M
Operating revenue 17.97%2.85B15.65%747.31M28.28%745.74M19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M
Cost of revenue 9.05%580.24M-1.30%136.14M47.18%188.46M-0.12%130.46M-7.60%125.18M5.77%532.06M-5.94%137.93M10.11%128.04M6.09%130.62M15.82%135.47M
Gross profit 20.48%2.27B20.24%611.17M22.94%557.28M25.16%581.57M13.60%523.65M18.46%1.89B30.03%508.28M16.51%453.29M13.15%464.66M14.55%460.94M
Operating expense 5.77%1.8B-6.48%449.8M16.81%443.41M15.54%461.12M11.71%445.19M10.79%1.7B19.24%480.98M-2.80%379.6M7.68%399.09M7.40%398.54M
Selling and administrative expenses 13.07%1.01B2.74%266.6M46.87%253.5M27.62%263.03M7.05%225.91M8.41%892.4M20.75%259.5M-20.39%172.6M4.71%206.1M8.43%211.02M
-Selling and marketing expense -2.40%476.7M-5.71%125.6M-10.66%108.9M6.23%122.8M----8.46%488.4M6.90%133.2M9.52%121.9M5.67%115.6M----
-General and administrative expense 31.76%532.3M11.64%141M185.21%144.6M54.95%140.23M----8.34%404M39.87%126.3M-51.94%50.7M3.51%90.5M----
Research and development costs 0.06%747.18M-15.87%173.51M-3.35%184.9M3.62%183.79M19.29%204.99M14.96%746.77M19.39%206.25M21.22%191.31M12.12%177.36M6.85%171.85M
Depreciation amortization depletion -30.39%43.3M-36.33%9.69M-68.06%5.01M-8.48%14.3M-8.76%14.3M-0.96%62.2M-3.03%15.23M-1.38%15.68M0.19%15.62M0.37%15.67M
-Depreciation and amortization -30.39%43.3M-36.33%9.69M-68.06%5.01M-8.48%14.3M-8.76%14.3M-0.96%62.2M-3.03%15.23M-1.38%15.68M0.19%15.62M0.37%15.67M
Operating profit 155.23%474.2M491.06%161.37M54.52%113.87M83.71%120.45M25.73%78.46M223.62%185.79M319.17%27.3M5,102.92%73.69M63.70%65.57M99.20%62.4M
Net non-operating interest income expense 41.51%62.15M1.18%15.04M26.12%15.09M83.03%16.21M91.97%15.82M1,110.95%43.92M123.60%14.86M3,637.81%11.96M754.14%8.86M514.90%8.24M
Non-operating interest income 28.36%74.88M-2.02%17.68M14.70%18.05M56.87%19.79M62.15%19.37M223.49%58.34M107.16%18.04M214.86%15.74M403.47%12.61M556.21%11.94M
Non-operating interest expense -10.74%12.34M-13.03%2.25M-21.46%2.97M-4.82%3.57M-4.21%3.55M0.07%13.82M75.99%2.59M-19.23%3.78M-2.69%3.76M-2.71%3.7M
Total other finance cost -34.18%391K----------------0.17%594K----------------
Other net income (expense) 113.95%5.33M65.47%-6.87M768.67%5.46M-25.30%-4.53M181.13%11.27M-142.40%-38.22M-95.96%-19.9M-15.56%-817K6.08%-3.61M-113.25%-13.89M
Special income (charges) --10M--0--0--0--10M--0--0--0--0--0
-Less：Restructuring and merger&acquisition --0------------------0----------------
-Gain on sale of property,plant,equipment --10M--0--0--0--10M--0--0--0--0--0
Other non- operating income (expenses) 87.78%-4.67M65.47%-6.87M768.67%5.46M-25.30%-4.53M109.12%1.27M-183.87%-38.22M-108.27%-19.9M-523.32%-817K-22.60%-3.61M-1,103.38%-13.89M
Income before tax 187.31%541.76M777.73%169.64M222.64%134.44M86.61%132.14M85.96%105.55M26.07%188.56M210.08%19.33M2,288.50%41.67M103.18%70.81M-57.70%56.76M
Income tax 449.31%114.9M4,364.89%44.7M2,096.82%28.36M69.00%24.96M185.94%16.89M160.99%20.92M93.95%-1.05M-72.81%1.29M105.51%14.77M-55.90%5.91M
Net income 154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M
Net income continuous Operations 154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M
Minority interest income
Net income attributable to the parent company 154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M
Basic earnings per share 152.81%2.25500.00%0.66166.67%0.5686.67%0.5674.07%0.4717.11%0.898,315.09%0.11625.00%0.21100.00%0.3-59.09%0.27
Diluted earnings per share 154.02%2.21481.82%0.64161.90%0.5589.66%0.5570.37%0.4616.00%0.878,315.09%0.11625.00%0.2193.33%0.29-57.14%0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meritage Homes
MTH
68.140
KB Home
KBH
54.030
D.R. Horton
DHI
126.340
4
Adobe
ADBE
374.980
5
Lennar Corp
LEN
108.610
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.